Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Hematopoietic Stem Cell Transplantation (HSCT) Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

Hematopoietic stem cell transplantation is a procedure in which multipotent hematopoietic stem cells sourced from peripheral blood cells, bone marrow, or umbilical cord blood are transplanted into the patient. Hematopoietic stem cell transplantation is commonly used in the treatment of lymphoma (Hodgkin, Non-Hodgkin), leukemia, multiple myeloma, thalassemia, sickle cell anemia, and osteoporosis. It includes two transplantation sources; 1) autologous, that uses stem cells from the patient's own body, 2) and allogeneic that sources stem cells from a donor's body. According to World Health Organization (WHO), over 50,000 hematopoietic stem cell transplantation procedures are carried out globally, every year and this number is expected to increase over the years.

Market Dynamics

The global hematopoietic stem cell transplantation market is expected to witness significant growth during the forecast period owing to the increasing prevalence of leukemia and lymphoma. According to Center for Disease Control and Prevention (CDC), in the U.S., around 45,360 people were diagnosed with leukemia in 2013, leading to 23,549 fatalities (13,625 men and 9,924 women). According to the same source the condition is more prevalent among men than women. Leukemia accounts for around 3% of all new cancer cases.

Key features of the study:

This report provides in-depth analysis of the global hematopoietic stem cell transplantation market, market size (US$ Mn), and compound annual growth rate (CAGR %) for the forecast period 2020-2027, considering 2019 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players

It profiles key players in the global hematopoietic stem cell transplantation market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key players covered as a part of this study are Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Kiadis Pharma, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio, Talaris Therapeutics, Inc., Marker Therapeutics Inc., and Stempeutics Research Pvt Ltd.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics

The global hematopoietic stem cell transplantation market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the hematopoietic stem cell transplantation market, research and consulting firms, new entrants, and financial analysts.

Key Topics Covered:

1. Research Objectives and Assumptions

Story continues

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers

Restraints

Market Opportunities

Impact Analysis

Key Developments

Pipeline Analysis

PEST Analysis

Reimbursement Scenario

Regulatory Scenario

Epidemiology

Government Initiatives

Treatment Algorithm

4. Impact Analysis of COVID-19

5. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Transplant Type, 2016 - 2027, (US$ Million)

Introduction

Market Share Analysis, 2020 and 2027 (%)

Y-o-Y Growth Analysis, 2017 - 2027

Segment Trends

Autologous

Introduction

Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

Allogeneic

Introduction

Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Indication, 2016 - 2027, (US$ Million)

Introduction

Market Share Analysis, 2020 and 2027 (%)

Y-o-Y Growth Analysis, 2017 - 2027

Segment Trends

Acute Myeloid Leukemia (AML)

Introduction

Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

Acute Lymphoblastic Leukemia (ALL)

Introduction

Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

Hodgkin lymphoma (HL)

Introduction

Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

Non-Hodgkin Lymphoma (NHL)

Introduction

Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

Multiple Myeloma (MM)

Introduction

Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

Other Non-malignant Disorders

Introduction

Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application, 2016 - 2027, (US$ Million)

Introduction

Market Share Analysis, 2020 and 2027 (%)

Y-o-Y Growth Analysis, 2017 - 2027

Segment Trends

Bone Marrow Transplant (BMT)

Introduction

Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

Peripheral Blood Stem Cells Transplant (PBSCT)

Introduction

Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

Cord Blood Transplant (CBT)

Introduction

Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

8. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Region, 2016 - 2027, (US$ Million)

Introduction

Market Share Analysis, By Region, 2020 and 2027 (%)

Y-o-Y Growth Analysis, By Region, 2017 - 2027

Regional Trends

North America

Market Size and Forecast, By Transplant Type, 2016 - 2027, (US$ Million)

Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)

Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)

Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)

U.S.

Canada

Europe

Market Size and Forecast, By Transplant Type, 2016 - 2027, (US$ Million)

Market Size and Forecast, By Indication, 2016 - 2027, (US$ Million)

Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)

Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)

U.K.

Germany

Italy

France

Link:
Insights on the Hematopoietic Stem Cell Transplantation Global Market to 2027 - Key Drivers, Restraints and Opportunities - Yahoo Finance

Bone Marrow Stem Cells Comments Off on Insights on the Hematopoietic Stem Cell Transplantation Global Market to 2027 – Key Drivers, Restraints and Opportunities – Yahoo Finance | August 6th, 2021